Training and Education About Substance Use Treatment

This report, the first in a series of three, examines four of the Substance Abuse and Mental Health Services Administration's grant programs that help alleviate suffering due to opioids and improve treatment quality and access. It offers recommendations about the existing reporting tools used by these programs and and proposes additional metrics and outcomes that should be considered.

This document provides a description of some best practices for designing and implementing a Substance Use Disorder (SUD)-focused health home state plan amendment based on the experiences of states with approved SUD-focused health home programs as required per section 1006(a)(2) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).

The goal of this guide is to provide interventions to treat for suicidal ideation, self-harm, and suicide attempts among youth. It provides research on implementation and examples of the ways that these recommendations can be implemented.

This infographics highlights the six priorities and related actions developed by the The National Action Alliance for Suicide Prevention launched the Mental Health & Suicide Prevention National Response to COVID-19 to foster a comprehensive and impactful response to the significant mental health and suicide prevention needs associated with the coronavirus pandemic.

The National Action Alliance for Suicide Prevention launched the Mental Health & Suicide Prevention National Response to COVID-19 steering committee of public and private sector leaders developed six priorities and related actions in order to foster a comprehensive and impactful response to the significant mental health and suicide prevention needs associated with the coronavirus pandemic.

The Action Alliance’s Mental Health & Suicide Prevention National Response to COVID-19 (National Response) is a diverse, nonpartisan public-private partnership committed to driving meaningful, lasting change in mental health and suicide prevention through collaboration, leadership, and action. The National Response is working to create sustainable and comprehensive solutions to the mental health impacts of this pandemic, while also preparing to address future needs by mitigating risks and building resiliency.

The U.S. Agency for Healthcare Research and Quality, on behalf of the U.S. Department of Health and Human Services, commissioned a rapid evidence review on the effectiveness of interventions to promote a broader understanding of the published literature on medication-assisted treatment retention among adults with opioid use disorder.

PCSS clinical experts have created a new Performance-in-Practice (PIP) activity that will help you identify and address gaps in your practice treating patients with opioid use disorder (OUD).

The Action Collaborative on Countering the U.S. Opioid Epidemic hosted a free public webinar on opioid tapering, utilizing experts in the field who discussed current guidance for opioid tapering, how it is applied in practice, and the strength of the evidence behind it. Five panelists presented various patient case scenarios and discussed pain management challenges through patient and caregiver perspectives, in order to inform best practices and identify evidence gaps.

This pocket guide is for drug court participants who may be prescribed or considering medication as a part of addiction treatment, as well as their families and support systems, including peer mentors, recovery coaches, and peer recovery specialists.